Class Action Lawsuit Filed Against ImmunityBio, Inc. (NASDAQ: IBRX) Over Alleged Securities Fraud

A class action lawsuit has been filed against ImmunityBio, Inc. (NASDAQ: IBRX) by Berger Montague PC, alleging securities fraud related to overstated performance of its Anktiva platform. The lawsuit claims that disclosures led to a 21% drop in the company's stock price, causing investor losses. Investors who purchased shares between January 19, 2026, and March 24, 2026, may seek to be appointed as lead plaintiffs by May 26, 2026.

By Berger Montague · PR Newswire · April 14, 2026, 16:09 UTC

Tickers: $IBRX

Topics: class action investor losses legal action securities fraud stock price drop

Read the full article at PR Newswire

More World news

Nvidia Appoints Colette Kress as Interim CEO Following Jensen Huang's Resignation CNBC · November 12, 2026, 16:59 UTC
Brookfield Corporation Reports Strong Third Quarter Earnings Growth and Increased Share Buybacks Motley Fool · November 12, 2026, 17:08 UTC
Franco-Nevada Reports Q3 2026 Revenue Growth Driven by Higher Gold and Oil Prices Motley Fool · November 12, 2026, 17:10 UTC
Stratasys Reports Q3 2026 Revenue Growth Driven by Aerospace and Defense Demand Motley Fool · November 12, 2026, 17:11 UTC
Jim Cramer Advises Profit-Taking Following Jensen Huang's Resignation at Nvidia CNBC · November 12, 2026, 16:59 UTC
LexisNexis Report Shows Elevated U.S. Auto Insurance Shopping Volumes in Q3 2026 PR Newswire · November 12, 2026, 17:12 UTC
Suburban Propane Partners Outlines $60M-$70M Capital Expenditures for Fiscal 2027 Seeking Alpha · November 12, 2026, 17:00 UTC
Nvidia, Supermicro, and Megaspeed Face U.S. Department of Justice Probes Seeking Alpha · November 12, 2026, 17:00 UTC
Starbucks Implements Quarterly Performance-Based Bonuses for Baristas Seeking Alpha · November 12, 2026, 17:03 UTC
Jim Cramer Analyzes Nvidia Leadership Transition and Recommends AMD, Constellation Brands, and Kimberly-Clark CNBC · November 12, 2026, 16:55 UTC